Mesothelioma, malignant (morphologic abnormality)
CONFIRM - Tissue Samples
Year Started: 2017
Tumour tissue samples are taken: a. After randomisation, and b. An OPTIONAL biopsy at 30 days post progression/ treatment discontinuation.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Male
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 51 - 75% |